Inhibikase Therapeutics logo
Inhibikase Therapeutics
IKT | NASDAQ
Chart Builder DCF Calculator
$1.45
-$0.07 (-4.61%)
At close: Nov 16, 2026, 4:00 PM ET
$1.45
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET

Inhibikase Therapeutics Statistics

Key statistics explained

Market Data

$285.56M
$92.24M
0.94
723.4K
196.94M
118.7%
67.67%
NASDAQ
US45719W2052

Price Performance

-12.1%
-39.3%
-9.9%
-29.3%
-4.6%
64.8%
-87.8%
-12.1%
-5.2%
-33.4%
-46.3%

Valuation

-3.22
N/A
-0.04
0.23
N/A
713.90
1.51
-5.73
-4.03
-5.80
N/A
-1.33
-1.33
-1.85
-31.0%
-17.4%
-24.8%

Financial Health

$193.32M
$0
$193.32M
$201.75M
15.34
15.34
0.00
-0.00
-0.00
N/A
0.00
12.45
3

Margins & Profitability

0.0%
0.0%
0.0%
0.0%
N/A
N/A
0.0%
-42.1%

Returns

-34.3%
-40.5%
-39.9%
-39.9%
-34.3%

Historical Growth (CAGR)

-150.0%
-58.0%
N/A
79.2%
42.7%
N/A
-52.7%
-27.4%
N/A

Analyst Forecasts

Hold
2
17.0%
N/A
Mar 25, 2027
-$0.11
22.2%
$400K
N/A

Fair Value Estimates

N/A
N/A
N/A
N/A
$5.00
244.8%

Cash Flow

$-49.37M
$-49.82M
$-70.79M
-$0.25
-$0.25
0.0%

Income Statement

$0
$0
$-75.27M
$-69.57M
$-69.17M
-$0.45
N/A
$-1.98M
35

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.